Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.004x

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a cash flow conversion efficiency ratio of -0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.19 Million ≈ $-1.49 Million USD) by net assets (CN¥2.63 Billion ≈ $385.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688639 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Anhui Huaheng Biotechnology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
INKON Life Technology Co Ltd SHE:300143	0.027x
Hextar Global Bhd KLSE:5151	0.095x
Quanex Building Products NYSE:NX	0.026x
Niutech Environment Technology Corp SHG:688309	0.063x
Beijing SL Pharmaceutical Co Ltd SHE:002038	0.013x
Risesun Real Estate Development Co Ltd SHE:002146	-0.025x
Jdd Tech New Mat Co Ltd SHE:301538	0.036x
Replimune Group Inc NASDAQ:REPL	-0.313x

Annual Cash Flow Conversion Efficiency for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Anhui Huaheng Biotechnology Co. Ltd. A (688639) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.63 Billion ≈ $385.12 Million	CN¥104.55 Million ≈ $15.30 Million	0.040x	-49.13%
2024-12-31	CN¥2.56 Billion ≈ $374.37 Million	CN¥199.79 Million ≈ $29.24 Million	0.078x	-53.14%
2023-12-31	CN¥1.83 Billion ≈ $267.15 Million	CN¥304.28 Million ≈ $44.53 Million	0.167x	-30.91%
2022-12-31	CN¥1.48 Billion ≈ $216.81 Million	CN¥357.43 Million ≈ $52.30 Million	0.241x	+198.23%
2021-12-31	CN¥1.18 Billion ≈ $173.13 Million	CN¥95.70 Million ≈ $14.00 Million	0.081x	-63.84%
2020-12-31	CN¥489.78 Million ≈ $71.67 Million	CN¥109.57 Million ≈ $16.03 Million	0.224x	-54.55%
2019-12-31	CN¥368.68 Million ≈ $53.95 Million	CN¥181.48 Million ≈ $26.56 Million	0.492x	+71.02%
2018-12-31	CN¥310.29 Million ≈ $45.41 Million	CN¥89.31 Million ≈ $13.07 Million	0.288x	-42.61%
2017-12-31	CN¥210.73 Million ≈ $30.84 Million	CN¥105.69 Million ≈ $15.47 Million	0.502x	+60.67%
2016-12-31	CN¥176.26 Million ≈ $25.79 Million	CN¥55.02 Million ≈ $8.05 Million	0.312x	+1.31%
2015-12-31	CN¥114.46 Million ≈ $16.75 Million	CN¥35.27 Million ≈ $5.16 Million	0.308x	-45.45%
2014-12-31	CN¥54.10 Million ≈ $7.92 Million	CN¥30.56 Million ≈ $4.47 Million	0.565x	-71.96%
2013-12-31	CN¥20.46 Million ≈ $2.99 Million	CN¥41.21 Million ≈ $6.03 Million	2.014x	+332.61%
2012-12-31	CN¥7.80 Million ≈ $1.14 Million	CN¥-6.76 Million ≈ $-988.72K	-0.866x	--

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology

Market Cap

$763.84 Million

CN¥5.22 Billion CNY

Market Cap Rank

#10274 Global

#2783 in China

Share Price

CN¥20.87

Change (1 day)

+0.87%

52-Week Range

CN¥20.48 - CN¥41.34

All Time High

CN¥85.44